Transforming molecular information
Go to content
Contact
IntegraGen on Twitter
IntegraGen on LinkedIn
IntegraGen - RSS feed
About Us
Company Overview
Management Team
Board of Directors
ISO 13485:2016 Certification
IntegraGen Genomics
Bioinformatics and Bioanalysis
News and Events
Press releases
Latest News
Upcoming Events
Investors
OncoDNA Friendly Takeover Bid
Corporate Presentations
Number of shares and voting rights
Press releases
Share Information
Calendar for Publications
Financial Documents
Financial Reports
Liquidity Contract
Shareholder Meetings
Investor Contacts
Join our mailing list
Contact Us
Office locations
Need Directions?
Contact form
Join our mailing list
Careers
Assisting you to make
treatment decisions
Learn more »
IntegraGen is a leader in genome analysis and the development and commercialization of molecular diagnostic tests for oncology.
Genomic Services
"Helping you to find"
Learn more
Bioinformatics & Bioanalysis
IntegraGen Genomics offers researchers advanced and personalized biostatistical tools and services to help analyze genomic research data.
Learn more
Investors
Learn more about IntegraGen
Learn more
Latest news
// Archive
Press releases
Agreement to file a friendly takeover bid initiated by ONCODNA on INTEGRAGEN
Press releases
IntegraGen reports sales of €4.7 million in the first half of 2020, up 13%, and cash position of €5.8 million
News
What’s new with MERCURY?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you consent to use our cookies.
Ok
